Outcomes

The evidence for retatrutide outcomes is currently limited, with most data coming from systematic reviews, meta-analyses, and ongoing clinical trials rather than published primary research studies.

Weight Loss Outcomes

Several meta-analyses have examined retatrutide's effects on weight loss in adults with overweight or obesity. These analyses suggest potential efficacy for weight reduction, though the specific magnitude of weight loss effects and the strength of underlying evidence are not detailed in the available abstracts.

Glycemic Control

Limited evidence suggests retatrutide may have effects on blood sugar control in adults with type 2 diabetes. One completed Phase 3 trial (TRANSCEND-T2D-1) evaluated retatrutide versus placebo in adults with type 2 diabetes and inadequate glycemic control, but results have not been published. An ongoing Phase 1 study is specifically examining effects on insulin secretion and insulin sensitivity.

Cardiovascular and Metabolic Parameters

A systematic review and meta-analysis specifically examined retatrutide's effects on blood pressure and lipid levels, suggesting potential benefits for these cardiovascular risk factors. However, the specific magnitude of these effects and the quality of underlying evidence are not clearly established from the available information.

Cognitive Effects

Preclinical research in diabetic rats suggests potential effects on learning and memory, though these animal study findings have limited applicability to human outcomes.

Safety Profile

The available evidence does not provide clear data on the safety profile or adverse event rates for retatrutide in human subjects.

Evidence Limitations: The current evidence base for retatrutide outcomes is notably limited. While multiple clinical trials are completed or ongoing, detailed results from these studies have not been published in peer-reviewed literature. The available systematic reviews and meta-analyses lack specific quantitative data on effect sizes, confidence intervals, or patient numbers, making it difficult to assess the clinical significance of reported outcomes.

This information is for educational purposes only and should not be considered personalized medical advice. Consult with a healthcare provider for medical decisions.

Retatrutide

Member access required